Gene Symbol | Gene ID | Gene Info |
---|---|---|
Obox1
|
ENSMUSG00000054310.10 | oocyte specific homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Obox1 | mm10_chr7_15967178_15967671 | -0.38 | 3.9e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_100025745_100025937 | 11.18 |
Gm33201 |
predicted gene, 33201 |
34626 |
0.17 |
chr13_81628689_81629170 | 9.61 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
4210 |
0.23 |
chr12_90132535_90132958 | 8.84 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr3_39047740_39047911 | 7.50 |
Gm43539 |
predicted gene 43539 |
38144 |
0.19 |
chr5_84848501_84849167 | 7.17 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr2_62341685_62342124 | 6.80 |
Dpp4 |
dipeptidylpeptidase 4 |
3242 |
0.24 |
chr1_81593373_81593581 | 6.62 |
Gm6198 |
predicted gene 6198 |
35994 |
0.2 |
chr10_103726584_103727032 | 6.57 |
Gm47224 |
predicted gene, 47224 |
131524 |
0.04 |
chr13_99516425_99517155 | 6.51 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr9_90700955_90701159 | 6.29 |
Gm2497 |
predicted gene 2497 |
32467 |
0.16 |
chr16_28752897_28753619 | 6.12 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr16_67611348_67611518 | 6.08 |
Cadm2 |
cell adhesion molecule 2 |
9060 |
0.25 |
chr8_65957067_65957218 | 6.03 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
10015 |
0.23 |
chr2_45227313_45227464 | 6.02 |
Gm28643 |
predicted gene 28643 |
70463 |
0.11 |
chr11_28735281_28735484 | 5.98 |
Mir216b |
microRNA 216b |
10809 |
0.13 |
chr14_117015447_117015598 | 5.98 |
Gpc6 |
glypican 6 |
89586 |
0.1 |
chr1_126865904_126866078 | 5.98 |
4930599A14Rik |
RIKEN cDNA 4930599A14 gene |
10598 |
0.26 |
chr1_47164093_47164266 | 5.93 |
Gm28826 |
predicted gene 28826 |
10718 |
0.28 |
chr15_91017743_91018222 | 5.92 |
Kif21a |
kinesin family member 21A |
31836 |
0.16 |
chr5_71095688_71096242 | 5.91 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
116 |
0.98 |
chr2_50971005_50971315 | 5.86 |
Gm13498 |
predicted gene 13498 |
61476 |
0.15 |
chr3_17790108_17790687 | 5.80 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
440 |
0.82 |
chr13_83727309_83727854 | 5.75 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr3_127750202_127750565 | 5.75 |
Gm23279 |
predicted gene, 23279 |
18789 |
0.1 |
chr1_172667830_172667985 | 5.63 |
Gm2710 |
predicted gene 2710 |
1729 |
0.3 |
chr4_23983504_23983750 | 5.47 |
Gm28448 |
predicted gene 28448 |
49673 |
0.19 |
chr17_13654565_13655321 | 5.41 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr15_25753970_25754154 | 5.40 |
Myo10 |
myosin X |
1083 |
0.59 |
chr10_22609004_22609241 | 5.35 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35889 |
0.16 |
chr8_76072766_76072955 | 5.33 |
Gm45742 |
predicted gene 45742 |
44167 |
0.15 |
chr10_79636972_79637781 | 5.25 |
Gm47163 |
predicted gene, 47163 |
480 |
0.42 |
chr19_47212130_47212315 | 5.20 |
Gm50339 |
predicted gene, 50339 |
9687 |
0.11 |
chr2_63669900_63670081 | 5.20 |
Gm23503 |
predicted gene, 23503 |
237796 |
0.02 |
chr1_139038190_139038368 | 5.18 |
Gm37470 |
predicted gene, 37470 |
8094 |
0.12 |
chr6_144313023_144313448 | 5.16 |
Sox5 |
SRY (sex determining region Y)-box 5 |
103667 |
0.08 |
chr2_62048238_62048412 | 5.16 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
1680 |
0.49 |
chrX_161926333_161926696 | 5.15 |
Gm15202 |
predicted gene 15202 |
18291 |
0.25 |
chr12_118660886_118661037 | 5.08 |
Gm9267 |
predicted gene 9267 |
58284 |
0.12 |
chr12_12723408_12723617 | 5.04 |
3732407C23Rik |
RIKEN cDNA 3732407C23 gene |
651 |
0.69 |
chr16_46982388_46982568 | 5.04 |
Gm6912 |
predicted gene 6912 |
91720 |
0.1 |
chr3_55351490_55352039 | 5.02 |
Dclk1 |
doublecortin-like kinase 1 |
2370 |
0.27 |
chr8_93917847_93918490 | 5.02 |
Gm24159 |
predicted gene, 24159 |
15768 |
0.16 |
chr19_28337285_28337436 | 5.01 |
Glis3 |
GLIS family zinc finger 3 |
11354 |
0.29 |
chr6_28980766_28981191 | 5.01 |
Gm3294 |
predicted gene 3294 |
656 |
0.73 |
chr1_41605098_41605443 | 4.94 |
Gm28634 |
predicted gene 28634 |
75727 |
0.12 |
chr16_77236770_77236921 | 4.93 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
526 |
0.83 |
chr1_105246144_105246553 | 4.93 |
Gm29013 |
predicted gene 29013 |
1923 |
0.41 |
chr2_19910475_19910626 | 4.92 |
Etl4 |
enhancer trap locus 4 |
770 |
0.63 |
chr1_88254702_88255947 | 4.91 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr6_148358988_148359145 | 4.90 |
Gm44020 |
predicted gene, 44020 |
271 |
0.88 |
chr16_44579610_44579783 | 4.89 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
20799 |
0.19 |
chr3_141112597_141112774 | 4.89 |
Pdha2 |
pyruvate dehydrogenase E1 alpha 2 |
99670 |
0.08 |
chr2_37931114_37931298 | 4.88 |
Dennd1a |
DENN/MADD domain containing 1A |
78766 |
0.08 |
chr4_23173209_23173360 | 4.87 |
Gm11884 |
predicted gene 11884 |
87500 |
0.1 |
chr7_88129795_88130052 | 4.86 |
Gm44846 |
predicted gene 44846 |
10765 |
0.2 |
chr4_21689447_21689958 | 4.85 |
Prdm13 |
PR domain containing 13 |
3739 |
0.21 |
chr3_42065851_42066002 | 4.84 |
Gm7899 |
predicted gene 7899 |
87878 |
0.08 |
chr3_139860895_139861104 | 4.82 |
Gm43678 |
predicted gene 43678 |
48235 |
0.17 |
chr1_127531215_127531971 | 4.79 |
Tmem163 |
transmembrane protein 163 |
5837 |
0.29 |
chr5_54763065_54763216 | 4.78 |
Gm43781 |
predicted gene 43781 |
44194 |
0.17 |
chr9_78881002_78881173 | 4.75 |
Gm47498 |
predicted gene, 47498 |
55696 |
0.11 |
chr11_35527923_35528248 | 4.75 |
Slit3 |
slit guidance ligand 3 |
16600 |
0.26 |
chr1_132200708_132201234 | 4.75 |
Lemd1 |
LEM domain containing 1 |
8 |
0.96 |
chr16_72610737_72610888 | 4.74 |
Robo1 |
roundabout guidance receptor 1 |
47112 |
0.2 |
chr15_25752476_25752687 | 4.73 |
Myo10 |
myosin X |
329 |
0.91 |
chr10_30328420_30328615 | 4.69 |
Gm4780 |
predicted gene 4780 |
44401 |
0.17 |
chr16_85967179_85967330 | 4.69 |
Gm49570 |
predicted gene, 49570 |
48201 |
0.16 |
chr14_12346789_12346985 | 4.65 |
Fezf2 |
Fez family zinc finger 2 |
928 |
0.45 |
chr12_117257705_117257898 | 4.64 |
Mir153 |
microRNA 153 |
6984 |
0.29 |
chr1_12689408_12689559 | 4.63 |
Sulf1 |
sulfatase 1 |
2794 |
0.24 |
chr4_22971277_22971442 | 4.63 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
32924 |
0.24 |
chr2_145859511_145860521 | 4.61 |
Rin2 |
Ras and Rab interactor 2 |
2628 |
0.24 |
chr8_49108663_49108821 | 4.61 |
Gm45829 |
predicted gene 45829 |
44863 |
0.17 |
chr3_105530220_105530411 | 4.60 |
Gm43847 |
predicted gene 43847 |
27408 |
0.18 |
chr3_159851998_159852454 | 4.60 |
Wls |
wntless WNT ligand secretion mediator |
3775 |
0.28 |
chr11_119157047_119157213 | 4.60 |
Mir6934 |
microRNA 6934 |
2993 |
0.18 |
chr4_139758638_139758809 | 4.58 |
Pax7 |
paired box 7 |
74284 |
0.08 |
chr7_73354299_73354479 | 4.57 |
Rgma |
repulsive guidance molecule family member A |
21120 |
0.13 |
chrX_61154776_61154939 | 4.57 |
Gm24396 |
predicted gene, 24396 |
9495 |
0.16 |
chr4_72167731_72168270 | 4.54 |
Gm11250 |
predicted gene 11250 |
768 |
0.7 |
chr2_41669936_41670198 | 4.52 |
Lrp1b |
low density lipoprotein-related protein 1B |
119011 |
0.07 |
chr10_118121607_118122166 | 4.50 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
9369 |
0.16 |
chr19_26704556_26705074 | 4.49 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
1356 |
0.52 |
chr9_117072436_117072996 | 4.48 |
Gm20397 |
predicted gene 20397 |
7189 |
0.25 |
chr13_72298631_72298782 | 4.46 |
Gm4052 |
predicted gene 4052 |
51515 |
0.15 |
chr9_37001994_37002204 | 4.45 |
Gm3896 |
predicted gene 3896 |
13659 |
0.15 |
chr4_74013078_74013818 | 4.43 |
Frmd3 |
FERM domain containing 3 |
4 |
0.98 |
chr6_10970567_10970901 | 4.43 |
AA545190 |
EST AA545190 |
3644 |
0.32 |
chr10_29213650_29213801 | 4.42 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
2020 |
0.29 |
chr1_177729767_177729918 | 4.42 |
1700016C15Rik |
RIKEN cDNA 1700016C15 gene |
28 |
0.98 |
chr7_76392345_76392603 | 4.40 |
Agbl1 |
ATP/GTP binding protein-like 1 |
18588 |
0.28 |
chr2_134929542_134929848 | 4.39 |
Gm14036 |
predicted gene 14036 |
125746 |
0.05 |
chr10_19277111_19277443 | 4.39 |
Gm33056 |
predicted gene, 33056 |
13712 |
0.19 |
chr7_119363899_119364114 | 4.38 |
Gm23321 |
predicted gene, 23321 |
57758 |
0.1 |
chr9_94839243_94839489 | 4.37 |
Mir7656 |
microRNA 7656 |
87537 |
0.09 |
chr13_29273638_29274140 | 4.36 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr4_5962683_5962879 | 4.36 |
Gm11797 |
predicted gene 11797 |
107093 |
0.07 |
chr3_130962179_130962620 | 4.36 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
25062 |
0.12 |
chr18_43556808_43557020 | 4.33 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
10043 |
0.19 |
chr8_98309461_98309682 | 4.32 |
Gm7192 |
predicted gene 7192 |
84908 |
0.1 |
chr13_25750886_25751367 | 4.31 |
Gm11350 |
predicted gene 11350 |
69983 |
0.13 |
chr7_129664007_129664606 | 4.27 |
Gm33248 |
predicted gene, 33248 |
3099 |
0.26 |
chr1_69023473_69023624 | 4.27 |
Gm16076 |
predicted gene 16076 |
83192 |
0.09 |
chr7_138398261_138398458 | 4.26 |
Tcerg1l |
transcription elongation regulator 1-like |
629 |
0.78 |
chr13_49319751_49319974 | 4.25 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
449 |
0.83 |
chr19_30826249_30826447 | 4.25 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
44896 |
0.2 |
chr4_48547198_48547367 | 4.23 |
Msantd3 |
Myb/SANT-like DNA-binding domain containing 3 |
6736 |
0.23 |
chr1_172328924_172329184 | 4.21 |
Kcnj9 |
potassium inwardly-rectifying channel, subfamily J, member 9 |
228 |
0.87 |
chr18_9216377_9216790 | 4.21 |
Fzd8 |
frizzled class receptor 8 |
4420 |
0.27 |
chr1_172203581_172203997 | 4.19 |
Pea15a |
phosphoprotein enriched in astrocytes 15A |
2908 |
0.13 |
chr10_58601473_58601858 | 4.19 |
Gm18042 |
predicted gene, 18042 |
46398 |
0.13 |
chr3_34558947_34559118 | 4.18 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1296 |
0.39 |
chr8_77518027_77518631 | 4.16 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
214 |
0.67 |
chr3_132086784_132086935 | 4.15 |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
1567 |
0.44 |
chr2_105720796_105721112 | 4.12 |
Gm13954 |
predicted gene 13954 |
11955 |
0.18 |
chr6_55700679_55700876 | 4.12 |
Gm3279 |
predicted gene 3279 |
16206 |
0.22 |
chrX_93300120_93300496 | 4.09 |
Arx |
aristaless related homeobox |
13798 |
0.23 |
chr17_63713151_63713302 | 4.09 |
Gm9300 |
predicted gene 9300 |
10736 |
0.25 |
chr13_101540430_101540989 | 4.07 |
Gm47533 |
predicted gene, 47533 |
4497 |
0.19 |
chr18_47568526_47568992 | 4.06 |
Gm5095 |
predicted gene 5095 |
31024 |
0.19 |
chr2_174919540_174919691 | 4.04 |
Gm14616 |
predicted gene 14616 |
63326 |
0.08 |
chrX_66649024_66649253 | 4.04 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
180 |
0.95 |
chr15_27811126_27811398 | 4.03 |
Trio |
triple functional domain (PTPRF interacting) |
12521 |
0.21 |
chr6_78245260_78245429 | 4.03 |
Gm5576 |
predicted pseudogene 5576 |
29466 |
0.21 |
chr16_73096919_73097070 | 4.03 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
1913 |
0.49 |
chr2_80129445_80129882 | 4.02 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
205 |
0.94 |
chr15_57747598_57747830 | 4.02 |
9330154K18Rik |
RIKEN cDNA 9330154K18 gene |
9048 |
0.22 |
chr5_13529208_13529396 | 4.01 |
Gm42676 |
predicted gene 42676 |
3579 |
0.23 |
chr16_37927274_37927446 | 3.99 |
Gpr156 |
G protein-coupled receptor 156 |
10864 |
0.17 |
chr1_85598209_85599024 | 3.98 |
Sp110 |
Sp110 nuclear body protein |
133 |
0.84 |
chr13_90335470_90335788 | 3.97 |
Gm37708 |
predicted gene, 37708 |
50928 |
0.14 |
chrX_22849813_22849966 | 3.97 |
Gm26131 |
predicted gene, 26131 |
12047 |
0.31 |
chr1_193433813_193434005 | 3.97 |
Gm38022 |
predicted gene, 38022 |
41381 |
0.11 |
chr10_42578232_42578446 | 3.96 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
2006 |
0.32 |
chr9_20682215_20682396 | 3.96 |
Olfm2 |
olfactomedin 2 |
9174 |
0.13 |
chr6_50823200_50823355 | 3.95 |
Gm44109 |
predicted gene, 44109 |
20246 |
0.14 |
chr18_42639041_42639192 | 3.95 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
16657 |
0.17 |
chr4_142267317_142267565 | 3.94 |
Kazn |
kazrin, periplakin interacting protein |
28040 |
0.2 |
chr13_36283759_36283936 | 3.94 |
Gm48766 |
predicted gene, 48766 |
31488 |
0.17 |
chr12_98107158_98107332 | 3.93 |
Gm47415 |
predicted gene, 47415 |
1316 |
0.48 |
chr9_60266870_60267276 | 3.93 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
67069 |
0.11 |
chr12_12676657_12677409 | 3.93 |
Gm27952 |
predicted gene, 27952 |
5585 |
0.18 |
chr2_83816359_83816510 | 3.93 |
Fam171b |
family with sequence similarity 171, member B |
3798 |
0.2 |
chr4_100828805_100829009 | 3.92 |
Cachd1 |
cache domain containing 1 |
52232 |
0.16 |
chr13_76808948_76809320 | 3.92 |
Mctp1 |
multiple C2 domains, transmembrane 1 |
16073 |
0.26 |
chr19_15803560_15803774 | 3.88 |
Gm50348 |
predicted gene, 50348 |
609 |
0.82 |
chr6_100030204_100030359 | 3.87 |
Gm33201 |
predicted gene, 33201 |
39066 |
0.16 |
chr3_105529884_105530167 | 3.87 |
Gm43847 |
predicted gene 43847 |
27118 |
0.18 |
chr3_55495868_55496193 | 3.86 |
Gm42607 |
predicted gene 42607 |
12242 |
0.14 |
chr2_91399403_91399554 | 3.86 |
Gm22071 |
predicted gene, 22071 |
7658 |
0.17 |
chr12_12753723_12753891 | 3.86 |
3732407C23Rik |
RIKEN cDNA 3732407C23 gene |
30946 |
0.14 |
chr5_4877110_4877333 | 3.86 |
Gm43111 |
predicted gene 43111 |
6955 |
0.15 |
chr14_64533719_64533870 | 3.86 |
Gm47202 |
predicted gene, 47202 |
3744 |
0.24 |
chr13_99937906_99938057 | 3.85 |
Mccc2 |
methylcrotonoyl-Coenzyme A carboxylase 2 (beta) |
23069 |
0.19 |
chr11_63246366_63246517 | 3.84 |
Gm12285 |
predicted gene 12285 |
4966 |
0.26 |
chr2_146015450_146015601 | 3.83 |
Cfap61 |
cilia and flagella associated protein 61 |
25969 |
0.2 |
chr9_14058858_14059227 | 3.82 |
1700019J19Rik |
RIKEN cDNA 1700019J19 gene |
30578 |
0.17 |
chr12_26635762_26635979 | 3.81 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33561 |
0.18 |
chr7_49699439_49699606 | 3.81 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59593 |
0.11 |
chr4_35807170_35807321 | 3.81 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
37959 |
0.23 |
chr1_73744671_73744860 | 3.81 |
6030407O03Rik |
RIKEN cDNA 6030407O03 gene |
818 |
0.66 |
chr5_133311271_133311422 | 3.80 |
Gm42625 |
predicted gene 42625 |
131996 |
0.05 |
chr12_7029541_7029692 | 3.80 |
Gm46311 |
predicted gene, 46311 |
62656 |
0.16 |
chr10_42071540_42071722 | 3.79 |
Tdg-ps2 |
thymine DNA glycosylase, pseudogene 2 |
16325 |
0.21 |
chr12_29095988_29096385 | 3.79 |
4833405L11Rik |
RIKEN cDNA 4833405L11 gene |
10551 |
0.23 |
chr13_25751437_25751638 | 3.79 |
Gm11350 |
predicted gene 11350 |
70394 |
0.13 |
chr2_139609748_139609937 | 3.79 |
Gm27385 |
predicted gene, 27385 |
21615 |
0.22 |
chr4_8097784_8097937 | 3.78 |
Gm11800 |
predicted gene 11800 |
20760 |
0.24 |
chr12_50967293_50967758 | 3.75 |
Gm40421 |
predicted gene, 40421 |
37348 |
0.16 |
chr17_88764144_88764434 | 3.74 |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
9767 |
0.24 |
chr1_68047124_68047492 | 3.74 |
Gm15671 |
predicted gene 15671 |
23065 |
0.22 |
chr3_73056881_73057482 | 3.74 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr16_63707323_63707577 | 3.73 |
Gm22769 |
predicted gene, 22769 |
40084 |
0.22 |
chr3_37569972_37570156 | 3.73 |
Spata5 |
spermatogenesis associated 5 |
3554 |
0.16 |
chrX_143518693_143518904 | 3.71 |
Pak3 |
p21 (RAC1) activated kinase 3 |
100 |
0.98 |
chr11_32087276_32087460 | 3.71 |
Gm12108 |
predicted gene 12108 |
13860 |
0.2 |
chr5_50122902_50123063 | 3.71 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
28351 |
0.18 |
chr12_106829459_106829610 | 3.70 |
1700013N06Rik |
RIKEN cDNA 1700013N06 gene |
8448 |
0.25 |
chr9_108460151_108461186 | 3.69 |
Ccdc71 |
coiled-coil domain containing 71 |
133 |
0.64 |
chr15_8815380_8815535 | 3.69 |
Gm5043 |
predicted gene 5043 |
99027 |
0.07 |
chr9_91040643_91040794 | 3.68 |
Gm5620 |
predicted gene 5620 |
56431 |
0.12 |
chr3_132744504_132744735 | 3.68 |
Gm42872 |
predicted gene 42872 |
22788 |
0.14 |
chr16_94179627_94180140 | 3.68 |
Hlcs |
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
4883 |
0.13 |
chr5_4834110_4834261 | 3.67 |
Gm43113 |
predicted gene 43113 |
6092 |
0.13 |
chr3_144223454_144223673 | 3.66 |
Lmo4 |
LIM domain only 4 |
18343 |
0.18 |
chr6_6174225_6174443 | 3.66 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
383 |
0.91 |
chr16_85889938_85890105 | 3.66 |
Adamts5 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
11807 |
0.25 |
chr4_91237120_91237301 | 3.65 |
Elavl2 |
ELAV like RNA binding protein 1 |
17372 |
0.25 |
chr3_55424227_55424378 | 3.65 |
Gm42609 |
predicted gene 42609 |
21180 |
0.15 |
chr6_53545704_53545864 | 3.64 |
Creb5 |
cAMP responsive element binding protein 5 |
27516 |
0.23 |
chr9_35363113_35363479 | 3.64 |
2610105M22Rik |
RIKEN cDNA 2610105M22 gene |
183 |
0.94 |
chr12_97978039_97978364 | 3.63 |
Gm35326 |
predicted gene, 35326 |
105681 |
0.06 |
chr16_94931404_94931589 | 3.62 |
Gm22745 |
predicted gene, 22745 |
62032 |
0.12 |
chr16_65964344_65964495 | 3.62 |
Gm49635 |
predicted gene, 49635 |
17313 |
0.24 |
chr3_81025915_81026237 | 3.61 |
Gm42476 |
predicted gene 42476 |
6878 |
0.16 |
chr6_22523629_22523780 | 3.60 |
Gm43630 |
predicted gene 43630 |
99214 |
0.07 |
chr5_48049041_48049318 | 3.60 |
Gm43426 |
predicted gene 43426 |
8872 |
0.18 |
chr10_29661899_29662050 | 3.60 |
Gm10275 |
predicted pseudogene 10275 |
37307 |
0.16 |
chr2_21283000_21283174 | 3.59 |
Gm13378 |
predicted gene 13378 |
38982 |
0.15 |
chr1_97929786_97929937 | 3.58 |
Gm3531 |
predicted pseudogene 3531 |
19528 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.6 | 4.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 4.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.3 | 6.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.3 | 2.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.3 | 3.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 3.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.2 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 3.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 4.2 | GO:0060594 | mammary gland specification(GO:0060594) |
1.0 | 3.0 | GO:0048880 | sensory system development(GO:0048880) |
0.9 | 2.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 1.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.9 | 3.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 4.2 | GO:0021764 | amygdala development(GO:0021764) |
0.8 | 4.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 2.4 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 2.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.8 | 4.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.7 | 3.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.7 | 2.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.7 | 3.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.7 | 0.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.7 | 1.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.7 | 2.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.7 | 2.0 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.7 | 2.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.7 | 3.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 2.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.6 | 1.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 4.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 3.8 | GO:0022605 | oogenesis stage(GO:0022605) |
0.6 | 1.9 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.6 | 0.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.6 | 1.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 1.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.6 | 1.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.6 | 2.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.6 | 1.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 1.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.6 | 1.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.6 | 1.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 3.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.6 | 4.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 0.5 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.5 | 2.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 1.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 1.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 4.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 3.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 4.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 1.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 2.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.5 | 1.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.5 | 2.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.5 | 0.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.5 | 0.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 4.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 2.2 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 2.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.4 | 0.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 1.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 1.3 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.4 | 2.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 1.7 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 0.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.4 | 1.6 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 2.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 0.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 1.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 3.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 1.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 1.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.4 | 0.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 1.5 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.4 | 2.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 1.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 1.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 3.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 1.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.3 | 1.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 19.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 3.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.7 | GO:0031223 | auditory behavior(GO:0031223) |
0.3 | 1.0 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 3.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 1.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 5.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 5.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 0.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 2.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 1.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.3 | 1.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.6 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 2.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 0.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.3 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 0.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 0.9 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 3.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 0.9 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 2.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 2.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 1.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 2.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.5 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 3.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 1.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 1.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 2.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.8 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 1.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.3 | GO:0070384 | Harderian gland development(GO:0070384) |
0.3 | 1.8 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 0.7 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) |
0.2 | 1.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.2 | 1.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 4.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 1.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 1.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 1.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 5.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 1.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 1.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 3.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 1.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 2.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.2 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 1.8 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 5.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.2 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 1.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 1.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 6.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.2 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.2 | 2.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 6.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 4.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.2 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 4.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 1.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.3 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 1.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 1.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.3 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 2.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.9 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.6 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 1.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.7 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.1 | 1.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 2.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 1.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 1.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 2.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 1.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.1 | 1.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 3.9 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.9 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.2 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.1 | 0.2 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.1 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.4 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.3 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.1 | 0.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.2 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 1.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.8 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.7 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.3 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.1 | 0.9 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 1.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 1.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.5 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.8 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.2 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 1.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.7 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 1.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 0.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.3 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.1 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.5 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 1.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.9 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 2.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.1 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:0098868 | bone growth(GO:0098868) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.2 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 1.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.0 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.0 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.0 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.6 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.0 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.0 | 0.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.0 | 0.0 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 4.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.1 | 7.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.0 | 4.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 2.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 7.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 4.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 2.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 6.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 4.7 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 1.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.5 | 1.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 2.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 2.4 | GO:0097433 | dense body(GO:0097433) |
0.5 | 1.4 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 0.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 0.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 6.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 1.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 2.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 1.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 3.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 13.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 2.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 1.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 2.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 4.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.8 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 2.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 3.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 3.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.3 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 5.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.5 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 5.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 1.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 4.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 3.7 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.0 | 6.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.9 | 5.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.5 | 4.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 3.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.1 | 4.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 4.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 4.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 2.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 2.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 3.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.9 | 3.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 2.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 2.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 4.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.7 | 3.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 5.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 3.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 1.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 1.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.6 | 6.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 1.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.5 | 4.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 1.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 1.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 2.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 1.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 1.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 2.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 2.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 7.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 1.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 11.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 8.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 2.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.9 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 6.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 3.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 2.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 2.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 2.2 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 3.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 3.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 1.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 2.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 3.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 2.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.9 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 3.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 1.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 3.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 1.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.1 | GO:0043909 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.4 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.2 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 2.4 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.3 | GO:0034580 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 2.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.1 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.6 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 1.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 16.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 4.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 3.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 2.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 4.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 8.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 6.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 3.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.5 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 10.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 6.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 15.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 3.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 3.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 4.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 5.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 1.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 3.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 6.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.5 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.7 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |